Al-Naamani et al. recently showed that lower vWF activity and cholesterol concentrations and higher NTproBNP concentrations at baseline were associated with an increased risk of death or lung transplantation in patients with PAH [2]. This evidence concerns the gene NPPB and pulmonary arterial hypertension.